October 27, 2025 a 03:43 pm

CI: Fundamental Ratio Analysis - Cigna Corporation

Cigna Corporation Stock Analysis

Cigna Corporation, a leader in the healthcare sector, is known for its diverse range of insurance products and services. The company's robust service offerings in healthcare plans make it a strong contender in the market. Despite challenges, its consistent performance in financial metrics indicates stability and growth potential.

Fundamental Rating

Cigna's fundamentals are strong with particular strength in Return on Assets and Discounted Cash Flow. Here's the detailed rating.

Category Score Score Bar
Discounted Cash Flow 5
Return on Equity 4
Return on Assets 5
Debt to Equity 1
Price to Earnings 3
Price to Book 3

Historical Rating

The historical rating reflects a stable performance with consistent metrics over the recent past.

Date Overall Score DCF ROE ROA Debt/Equity P/E P/B
2025-10-27 4 5 4 5 1 3 3
Previous 0 5 4 5 1 3 3

Analyst Price Targets

Analysts maintain a positive outlook with a consensus of "Buy". Here are the detailed price targets.

High Low Median Consensus
$415 $354 $378.5 $380.75
Stock Chart of Cigna Corporation

Analyst Sentiment

The sentiment among analysts remains overwhelmingly positive with a majority recommending Buy.

Recommendation Number Distribution Bar
Strong Buy 1
Buy 28
Hold 9
Sell 0
Strong Sell 0

Conclusion

Cigna Corporation seems to be in a robust position with strong fundamentals and a favorable outlook from analysts. The stock's promising performance in key financial metrics and positive analyst sentiment make it an intriguing investment. The major risk lies in its elevated debt-to-equity ratio, which could impact future flexibility. Nonetheless, the overall stability and growth potential present Cigna as a solid contender in the healthcare industry. Investors might consider this stock a valuable addition to their portfolios with mindful observation of market conditions.